Minimally invasive treatment combined with cytokine-induced killer cells therapy lower the short-term recurrence rates of hepatocellular carcinomas.

Source:http://linkedlifedata.com/resource/pubmed/id/18157013

Download in:

View as

General Info

PMID
18157013